RGD-Conjugated Resveratrol HSA Nanoparticles as a Novel Delivery System in Ovarian Cancer Therapy

BACKGROUND: To establish a novel delivery system of RGD-conjugated resveratrol human serum albumin (HAS) nanoparticles in ovarian cancer therapy. METHODS: The nanoparticles system was characterized for physicochemical properties, the stability in the serum and in vitro release. The comparison betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Qifang, Zhu, Weipei, Guo, Liangsheng, Pu, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779302/
https://www.ncbi.nlm.nih.gov/pubmed/33408463
http://dx.doi.org/10.2147/DDDT.S248950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779302/
https://www.ncbi.nlm.nih.gov/pubmed/33408463
http://dx.doi.org/10.2147/DDDT.S248950

Ejemplares similares